Please use this identifier to cite or link to this item:
Title: Heparanase expression and glycosaminoglycans profile in renal cell carcinoma
Authors: Batista, Lucas Teixeira e Aguiar [UNIFESP]
Matos, Leandro Luongo [UNIFESP]
Machado, Leopoldo Ruiz
Suarez, Eloah Rabello [UNIFESP]
Theodoro, Therese Rachell
Maciel Martins, Joao Roberto [UNIFESP]
Nader, Helena Bonciani [UNIFESP]
Lima Pompeo, Antonio Carlos
Silva Pinhal, Maria Aparecida da [UNIFESP]
Universidade Federal de São Paulo (UNIFESP)
Keywords: chondroitin sulfate
dermatan sulfate
extracellular matrix
heparan sulfate
Issue Date: 1-Nov-2012
Publisher: Wiley-Blackwell
Citation: International Journal of Urology. Hoboken: Wiley-Blackwell, v. 19, n. 11, p. 1036-1040, 2012.
Abstract: A better understanding of the molecular mechanisms of renal cell carcinogenesis could contribute to a decrease in the mortality rate of this disease. the aim of this study was to evaluate the glycosaminoglycans profile and heparanase expression in renal cell carcinoma. the study included 24 patients submitted to nephrectomy with confirmed pathological diagnosis of renal cell carcinoma. the majority of the samples (87.5%) were classified in the initial stage of renal cell carcinoma (clinical stages I and II). Heparanase messenger ribonucleic acid expression was evaluated by quantitative real-time reverse transcription polymerase chain reaction, and sulfated glycosaminoglycans were identified and quantified by agarose gel electrophoresis of renal cell carcinoma samples or non-neoplastic tissues obtained from the same patients (control group). the sulfated glycosaminoglycans and hyaluronic acid were analyzed in urine samples of the patients before and after surgery. the data showed a significant statistical increase in chondroitin sulfate, and a decrease in heparan sulfate and dermatan sulfate present in neoplastic tissues compared with non-neoplastic tissues. Higher heparanase messenger ribonucleic acid expression in the neoplastic tissues was also shown, compared with the non-neoplastic tissues. the urine glycosaminoglycans profile showed no significant difference between renal cell carcinoma and control samples. Extracellular matrix changes observed in the present study clarify that heparanase is possibly involved with heparan sulfate turnover, and that heparanase and the glycosaminoglycans can modulate initial events of renal cell carcinoma development.
ISSN: 0919-8172
Other Identifiers:
Appears in Collections:Em verificação - Geral

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.